Strategic plans go back a long way in the genomics field. The first plan mapped the path for sequencing the human genome, followed by slight recalibrations as the work and technology advanced. The next big plan centered on what to do after the human genome was completed. That, National Human Genome Research Institute Director Eric Green says, "served the field well," though it eventually became dated. "We looked at it and said, 'Wow, it's getting a little gray,'" Green says. "Once again, technology — sequencing in particular — has advanced much more than we ever anticipated.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.